30
Apr

Mirna Therapeutics hauled in a $41.8 million D round to get its RNA treatment into Phase II trials, assembling a big-name syndicate to back its ambitions in immuno-oncology.

…read more

Source: Mirna rallies major players for $42M round, hits the gas in immuno-oncology

    

0 No comments